Lemierre syndrome

Southern Medical Journal

Volumn 105, Issue 5, 2012, Pages 283-288

  Wright, William F ^a,b   Shiner, Christine N ^a,b   Ribes, Julie A ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Kentucky   (United States)

Author keywords

anaerobic postanginal sepsis; Lemierre syndrome; necrobacillosis

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; ENOXAPARIN; HEPARIN; IMIPENEM; LOW MOLECULAR WEIGHT HEPARIN; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ANTIBIOTIC RESISTANCE; ASPIRATION PNEUMONIA; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG CHOICE; ECHOGRAPHY; FUSOBACTERIA; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NECROPHORUM; HOSPITAL ADMISSION; HUMAN; INTERNAL JUGULAR VEIN; INTERNAL MEDICINE; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; LEMIERRE SYNDROME; LUNG ABSCESS; LUNG EMBOLISM; MEDICAL CARE; MICROBIAL ACTIVITY; MOUTH INFECTION; NECK PAIN; NONHUMAN; PATHOGENESIS; PHARYNGITIS; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SYMPTOM; THROMBOEMBOLISM; TREATMENT DURATION; TRICUSPID VALVE DISEASE; UNITED STATES; VEIN EMBOLISM; VEIN THROMBOSIS;

ANTI-BACTERIAL AGENTS; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NECROPHORUM; HUMANS; LEMIERRE SYNDROME; PHARYNGITIS;

EID: 84861091789     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31825581ef     Document Type: Review

References (45)

1. Hagelskjaer Kristensen L, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis 2000;31:524-532.
2. Riordan T, Wilson M. Lemierre's syndrome: more than a historical curiosa. Postgrad Med J 2004;80:328-334.
3. Chirinos JA, Lichenstein DM, Garcia J, et al. The evolution of Lemierre syndrome: report of 2 cases and review of the literature. Medicine (Baltimore) 2002;81:458-465.
4. Riordan T. Human infection with Fusobacterium necrophorum (necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev 2007;20:622-659.
5. Karkos PD, Asrani S, Karkos CD, et al. Lemierre's syndrome: a systematic review. Laryngoscope 2009;119:1552-1559.
6. Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1936; ii: 601-703.
7. Vogel LC, Boyer KM. Metastatic complications of Fusobacterium necrophorum sepsis. Two cases of Lemierre's postanginal septicemia. Am J Dis Child 1980;134:356-358.
8. Seidenfeld SM, Sutker WL, Luby JP. Fusobacterium necrophorum septicemia following oropharyngeal infection. JAMA 1982;248:1348-1350.
9. Shannon GW, Ellis CV, Stepp WP. Oropharyngeal Bacteroides melaninogenicus infection with septicemia: Lemierre's syndrome. J Fam Pract 1983;16:159-160, 163, 166.
10. Moore B, Dekle C, Werkhaven J. Bilateral Lemierre's syndrome: a case report and literature review. Ear Nose Throat J 2002;81:234-236, 238-240, 242.
11. Hagelskjaer LH, Prag J, Malczynski J, et al. Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome, in Denmark 1990Y 1995. Eur J Clin Microbiol Infect Dis 1998;17:561-565.
12. Hagelskjaer Kristensen L, Prag J. Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. Eur J Clin Microbiol Infect Dis 2008;27:779-789.
13. Ramirez S, Hild TG, Rudolph CN, et al. Increased diagnosis of Lemierre's syndrome and other Fusobacterium necrophorum infections at a children's hospital. Pediatrics 2003;112:e380-e385.
14. Brazier JS, Hall V, Yusuf E, et al. Fusobacterium necrophorum infections in England and Wales 1990-2000. J Med Microbiol 2002;51:269-272.
15. Venglarcik J. Lemierre's syndrome. Pediatr Infect Dis J 2003;22:921-923.
16. Weeks DF, Katz DS, Saxon P, et al. Lemierre syndrome: report of five new cases and literature review. Emerg Radiol 2010;17:323-328.
17. Chacko EM, Krilov LR, Patten W, et al. Lemierre's and Lemierre's-like syndromes in association with infectious mononucleosis. J Laryngol Otol 2010;124:1257-1262.
18. Ridgway JM, Parikh DA, Wright R, et al. Lemierre syndrome: a pediatric case series and review of literature. Am J Otolaryngol 2010;31:38-45.
19. Bondy P. Lemierre's syndrome: what are the roles of anticoagulation and long-term antibiotic therapy? Ann Otol Rhinol Laryngol 2008;117:679-683.
20. Tan ZL, Nagaraja TG, Chengappa MM. Fusobacterium necrophorum infections: virulence factors, pathogenic mechanism and control measures. Vet Res Commun 1996;20:113-140.
21. Brazier JS. Human infections with Fusobacterium necrophorum. Anaerobe 2006;12:165-172.
22. Forrester LJ, Campbell BJ, Berg JN, et al. Aggregation of platelets by Fusobacterium necrophorum. J Clin Microbiol 1985;22:245-249.
23. Kikkert R, Laine ML, Aarden LA, et al. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol 2007;22:145-151.
24. Liu H, Redline RW, Han YW. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J Immunol 2007;179:2501-2508.
25. Razonable RR, Rahman AE, Wilson WR. Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess. Mayo Clin Proc 2003;78:1153-1156.
26. Friberg N, Carlson P, Kentala E, et al. Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum. J Immunol 2008;181:8624-8632.
27. Holm K, Frick IM, Bjorck L, et al. Activation of the contact system at the surface of Fusobacterium necrophorum represents a possible virulence mechanism in Lemierre's syndrome. Infect Immun 2011;79:3284-3290.
28. Tarnvik A. Anaerobic meningitis in children. Eur J Clin Microbiol 1986;5:271-274.
29. Screaton NJ, Ravenel JG, Lehner PJ, et al. Lemierre syndrome: forgotten but not extinct-report of four cases. Radiology 1999;213:369-374.
30. Nguyen-Dinh KV, Marsot-Dupuch K, Portier F, et al. Lemierre syndrome: usefulness of CT in detection of extensive occult thrombophlebitis. J Neuroradiol 2002;29:132-135.
31. Kowalsky SF, Echols RM, McCormick EM. Comparative serum bactericidal activity of ceftizoxime/metronidazole, ceftizoxime, clindamycin, and imipenem against obligate anaerobic bacteria. J Antimicrob Chemother 1990;25:767-775.
32. Appelbaum PC, Spangler SK, Jacobs MR. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U. S. centers. Antimicrob Agents Chemother 1990;34:1546-1550.
33. Moreno S, Garcia-Altazano J, Pinilla B, et al. Lemierre's disease: postanginal bacteremia and pulmonary involvement caused by Fusobacterium necrophorum. Rev Infect Dis 1989;11:319-324.
34. Ahkee S, Srinatha L, Huang A, et al. Lemierre's syndrome: postanginal sepsis due to anaerobic oropharyngeal infection. Ann Otol Rhinol Laryngol 1994;103:208-210.
35. Ma M, Jauch EC, Johnson MC. A case of Lemierre's syndrome. Eur J Emerg Med 2003;10:139-142.
36. Leugers CM, Clover R. Lemierre syndrome: postanginal sepsis. J Am Board Fam Pract 1995;8:384-391.
37. Armstrong AW, Spooner K, Sanders JW. Lemierre's syndrome. Curr Infect Dis Rep 2000;2:168-173.
38. Falagas M, Vardakas KZ, Athanasiou S. Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: a systematic review. Eur J Pharmacol 2007;557:93-98.
39. Bach MC, Roediger JH, Rinder HM. Septic anaerobic jugular phlebitis with pulmonary embolism: problems in management. Rev Infect Dis 1988;10:424-427.
40. Goldhagen J, Alford BA, Prewitt LH, et al. Suppurative thrombophlebitis of the internal jugular vein: report of three cases and review of the pediatric literature. Pediatr Infect Dis J 1988;7:410-414.
41. Hoehn KS. Lemierre's syndrome: the controversy of anticoagulation. Pediatrics 2005;115:1415-1416.
42. Mai C, Hunt D. Upper-extremity deep venous thrombosis: a review. Am J Med 2011;124:402-407.
43. Rathbun SW, Stoner JA, Whitsett TL. Treatment of upper-extremity deep vein thrombosis. J Thromb Haemost 2011;9:1924-1930.
44. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 suppl):454S-545S.
45. Hodgson R, Emiq M, Pisarello J. Hyperbaric oxygen (HBO2) in the treatment of Lemierre syndrome. Undersea Hyerb Med 2003;30:87-91.